Gene · 3459
Papers3,929
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 3,929
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Interferon-gamma-inducible protein 30 prevents IFN-γ-receptor 1 degradation to maintain PD-L1 and MHC-II levels in metastatic melanoma. | Cell Commun Signal | 2026 | 41680804 | PubTator, text mining | PubMed |
| Harnessing Inflammatory Monocytes to Overcome Resistance to Anti-PD-1 Immunotherapy. | bioRxiv | 2026 | 41676732 | PubTator, text mining | PubMed |
| Nanoparticle approaches for hepatitis therapy and clinical translation. | Discov Nano | 2026 | 41649705 | PubTator, text mining | PubMed |
| Complete and partial forms of X-linked MCTS1 deficiency in patients with mycobacterial disease. | J Hum Immun | 2026 | 41623352 | PubTator, text mining | PubMed |
| TBKBP1 induces capecitabine resistance through negative regulation of type I interferon pathway in triple-negative breast cancer. | Oncogene | 2026 | 41606294 | PubTator, text mining | PubMed |
| The value of immunogenic cell death-related gene model in the prognosis of gastric cancer. | Discov Oncol | 2026 | 41604037 | PubTator, text mining | PubMed |
| Regulatory dynamics of IFI44L in systemic lupus erythematosus: the interplay of type I interferon and c-Jun. | Lupus Sci Med | 2026 | 41592906 | PubTator, text mining | PubMed |
| IFNγ-dependent metabolic reprogramming restrains an immature, pro-metastatic lymphatic state in melanoma. | Cancer Cell | 2026 | 41576931 | PubTator, text mining | PubMed |
| Immunotherapy Response Predictive Score Based on Tumor Microenvironment Profiles for Predicting Immunotherapy Outcomes in Advanced Head and Neck Cancer. | Technol Cancer Res Treat | 2026 | 41574715 | PubTator, text mining | PubMed |
| CDK2 inhibitor BLU-222 synergizes with CDK4/6 inhibitors in drug resistant breast cancers through p21/p27 induction. | Nat Commun | 2026 | 41571637 | PubTator, text mining | PubMed |
| CRISPR screens in the context of immune selection identify CHD1 and MAP3K7 as mediators of cancer immunotherapy resistance. | Cell Rep Med | 2026 | 41564866 | PubTator, text mining | PubMed |
| A distinct monocyte transcriptional state links systemic immune dysregulation to pulmonary impairment in long COVID. | Nat Immunol | 2026 | 41535626 | PubTator, text mining | PubMed |
| Genetic influence of IFN-γ gene polymorphisms on hepatitis C progression and recovery. | J Virol Methods | 2026 | 41506323 | PubTator, text mining | PubMed |
| Microglial transcriptional profiles of a transgenic rat model closely model Alzheimer's disease. | J Alzheimers Dis | 2026 | 41490158 | PubTator, text mining | PubMed |
| Large-Scale Blood Proteomic Analysis Across Different Inflammatory Skin Conditions Reveals Extensive Immune Dysregulation With Distinct Biomarker Profiles. | Allergy | 2026 | 41246813 | PubTator, text mining | PubMed |
| Core Neuroinflammatory Pathways Contributing to Delayed Encephalopathy After Acute Carbon Monoxide Poisoning Revealed by Multi-omics and Single Nucleus RNA-Seq. | Curr Med Chem | 2026 | 40626535 | PubTator, text mining | PubMed |
| A patient with complete IFN-γR1 deficiency and tuberculosis resembling BCG disease. | J Hum Immun | 2025 | 42169986 | PubTator, text mining | PubMed |
| From anonymity to stardom: history of nontuberculous mycobacterial disease in humans. | Front Cell Infect Microbiol | 2025 | 41808770 | PubTator, text mining | PubMed |
| Targeting Impaired Type I Interferon-IL-27 Signaling Rescues T Regulatory Cell Suppressive Function in Relapsing-Remitting Multiple Sclerosis. | bioRxiv | 2025 | 41783369 | PubTator, text mining | PubMed |
| Upregulation of interferon-γ activation in patients with anti-interferon-γ autoantibodies immunodeficiency syndrome: insights from single-cell analysis. | Front Immunol | 2025 | 41710026 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3459/papers?page=4